tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market
Advertisement

Biosyent (RX) Financial Statements

Compare
50 Followers

Biosyent Financial Overview

Biosyent's market cap is currently C$137.48M. The company's EPS TTM is C$0.18; its P/E ratio is 16.47; and it has a dividend yield of 1.63%. Biosyent is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in CAD

Biosyent Earnings and Revenue History

Biosyent Debt to Assets

Biosyent Cash Flow

Biosyent Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis